Vicus Capital
IBB icon

Vicus Capital’s iShares Biotechnology ETF IBB Stock Holding History

Vicus Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.12M Buy
+24,302
New +$4.88M 0.32% 57
2019
Q2 		– Sell
-1,910
Closed -$214K – 234
2019
Q1 		$214K Sell
1,910
-458
-19% -$50.2K 0.03% 219
2018
Q4 		$228K Buy
2,368
+73
+3% +$7.75K 0.04% 200
2018
Q3 		$280K Sell
2,295
-706
-24% -$83.1K 0.05% 192
2018
Q2 		$330K Sell
3,001
-594
-17% -$63.5K 0.05% 183
2018
Q1 		$384K Sell
3,595
-661
-16% -$73.3K 0.07% 169
2017
Q4 		$454K Sell
4,256
-55
-1% -$5.88K 0.08% 156
2017
Q3 		$480K Sell
4,311
-18
-0.4% -$1.92K 0.09% 152
2017
Q2 		$448K Sell
4,329
-465
-10% -$45.8K 0.09% 151
2017
Q1 		$469K Buy
4,794
+72
+2% +$6.89K 0.1% 148
2016
Q4 		$418K Sell
4,722
-1,371
-23% -$125K 0.09% 153
2016
Q3 		$588K Sell
6,093
-354
-5% -$33.7K 0.13% 127
2016
Q2 		$553K Buy
6,447
+636
+11% +$57.1K 0.13% 115
2016
Q1 		$505K Sell
5,811
-10,638
-65% -$951K 0.11% 115
2015
Q4 		$1.86M Sell
16,449
-37,341
-69% -$4.05M 0.47% 59
2015
Q3 		$5.44M Sell
53,790
-5,259
-9% -$631K 1.44% 23
2015
Q2 		$7.26M Buy
59,049
+3,423
+6% +$410K 1.89% 17
2015
Q1 		$6.37M Buy
55,626
+5,304
+11% +$585K 1.23% 18
2014
Q4 		$5.09M Buy
+50,322
New +$4.89M 1.47% 21

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Commerce Bank
Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Vicus Capital's IBB Position: Q3 2026 in Review

Vicus Capital opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 24,302 shares worth $5.12M. The stake represents 0.32% of the portfolio and ranks #57 among its holdings. This is a return to the name: Vicus Capital previously reported a position in IBB as recently as Q1 2019.

Vicus Capital first reported a position in IBB in Q4 2014 and has held it in 19 quarters since. The position peaked at $7.26M in Q2 2015. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Vicus Capital held 24,302 shares of iShares Biotechnology ETF worth $5.12M as of Q3 2026.
  • iShares Biotechnology ETF was a new Vicus Capital position in Q3 2026.
  • iShares Biotechnology ETF made up 0.32% of Vicus Capital's portfolio in Q3 2026, its #57 holding.
  • Vicus Capital first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 19 quarters since.
  • Vicus Capital's iShares Biotechnology ETF position peaked at $7.26M in Q2 2015.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Vicus Capital's 13F filing for Q3 2026, filed 5 Nov 2026.